Orfeu Flores

 

Dr. Orfeu Flores, holds a Degree in Applied Chemistry (1992) from Universidade Nova de Lisboa, Portugal, a M.Sc. in Science and Technology Commercialization (1998) from Texas University, USA, and a PhD in Molecular Genetics (2015) from Universidade Nova de Lisboa, Portugal. He is the Founder and CEO of STAB VIDA, holding a large experience in biotech entrepreneurship, and having received several Entrepreneurship Awards by the Portuguese Association of Young Entrepreneurs, the Rotary Foundation and the Gulbenkian Foundation. He is also an expert for European Commission RTD FP5, FP6, FP7 and H2020, member of several panels for project evaluation, since 1999; Project Technical Assistant for European Commission RTD FP6 in Genomics and diseases of genetic origin, since April 2000, having been also coordinator of several projects.

 

PANA Project

​

Alzheimer’s disease (AD) is a vital medical/social problem in EU, but currently, there is not an effective method for the early diagnosis of AD.

Integrated by neuroscientists, nanotechnologists, molecular imaging experts, clinicians and Small/Medium/Large Enterprises in an exclusive consortium, PANA project seeks the goal to develop new effective early diagnostic and therapeutic strategies to help in delaying the appearance of the most adverse symptoms of this disease, using nanotechnology.